(Q28192714)

English

Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE

scientific article (publication date: October 2005)

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE (English)

0 references

4

object named as

Klaus K Witte

0 references

1

object named as

John G F Cleland

0 references

author name string

Alison P Coletta

2

0 references

Mike Lammiman

3

0 references

Huan Loh

5

0 references

Mansoor Nasir

6

0 references

Andrew L Clark

7

0 references

language of work or name

0 references

publication date

October 2005

0 references

European Journal of Heart Failure

0 references

7

0 references

6

0 references

1070-5

0 references

Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Baseline characteristics of patients recruited into the CARE-HF study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Clinical trials update from the American Heart Association meeting: Omega-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, OR

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.006

21 January 2018

Identifiers

10.1016/J.EJHEART.2005.09.006

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28192714&oldid=2116367877"